Review
Aug 2026
Neuroinflammatory and molecular pathways in Alzheimer's disease: mechanistic crosstalk and emerging therapeutic opportunities.
Overall, this review makes a case for integrative, pathway-based therapeutic models, and multiple approaches may facilitate for drug development, biomarker identification and patient management in Alzheimer's disease.
Abhay Thakur, Rohit Sharma, Sneha Kumari et al.
· InflammoPharmacology · 0 citations